Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Precision BioSciences (DTIL) Misses Q2 EPS by 2c

August 8, 2022 7:04 AM EDT

Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.46), $0.02 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $4.97 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

... More